Recent advances in the metabolism of cannabinoids
- PMID: 7584607
- DOI: 10.1016/1357-2725(95)00043-o
Recent advances in the metabolism of cannabinoids
Erratum in
- Int J Biochem Cell Biol 1995 Dec;27(12):1365
Abstract
This review describes recent advances in the metabolism of cannabinoids. Cannabidiol was metabolized to cannabielsoin, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol and an oxepine derivative through epoxide intermediates by hepatic microsomal enzymes containing cytochrome P450 of animals. Cannabidiol inactivated cytochrome P450 UT-2 (CYP2C11) not equal to in male rats and a member of 3A subfamily in mouse liver. These inactivations may be very important because serious drug-drug interactions will occur in the case that cannabidiol is co-administered with drugs which are metabolized mainly by the enzyme system containing these P450 isozymes. A member of cytochrome P450 belonging to 2C subfamily was the major isozymes responsible for the cannabinoid metabolism in many experimental animals and that of 3A subfamily made some contribution to the metabolism of cannabinoids by human hepatic microsomes. Microsomal aldehyde oxygenase, a particular isozyme of cytochrome P450 catalyzing the oxidation of 11-oxo-tetrahydrocannabinol to tetrahydrocannabinol-11-oic acid, was found for the first time by the authors. Cytochrome P450 MUT-2 (CYP2C29) is the major isozyme responsible for the microsomal aldehyde oxygenase activity in mouse hepatic microsomes.
Similar articles
-
A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes.Biochem Pharmacol. 1993 Aug 3;46(3):405-11. doi: 10.1016/0006-2952(93)90516-y. Biochem Pharmacol. 1993. PMID: 8394082
-
Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.Biochem Pharmacol. 1991 Aug 22;42(6):1255-9. doi: 10.1016/0006-2952(91)90262-4. Biochem Pharmacol. 1991. PMID: 1653566
-
Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman.Biol Pharm Bull. 1995 Aug;18(8):1138-41. doi: 10.1248/bpb.18.1138. Biol Pharm Bull. 1995. PMID: 8535411
-
Cannabinoids and Cytochrome P450 Interactions.Curr Drug Metab. 2016;17(3):206-26. doi: 10.2174/1389200217666151210142051. Curr Drug Metab. 2016. PMID: 26651971 Review.
-
Cannabis and Cannabinoids: Kinetics and Interactions.Am J Med. 2019 Nov;132(11):1266-1270. doi: 10.1016/j.amjmed.2019.05.017. Epub 2019 May 30. Am J Med. 2019. PMID: 31152723 Review.
Cited by
-
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.J Inorg Biochem. 2018 Jul;184:88-99. doi: 10.1016/j.jinorgbio.2018.03.016. Epub 2018 Apr 7. J Inorg Biochem. 2018. PMID: 29689453 Free PMC article.
-
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats.Neuropharmacology. 2011 Feb-Mar;60(2-3):274-83. doi: 10.1016/j.neuropharm.2010.09.010. Epub 2010 Sep 17. Neuropharmacology. 2011. PMID: 20850461 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of cannabinoids.Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
-
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.Front Vet Sci. 2018 Jul 23;5:165. doi: 10.3389/fvets.2018.00165. eCollection 2018. Front Vet Sci. 2018. PMID: 30083539 Free PMC article.
-
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.Clin Pharmacokinet. 1997 Mar;32(3):210-58. doi: 10.2165/00003088-199732030-00004. Clin Pharmacokinet. 1997. PMID: 9084960 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources